What's happening to the Medibank (ASX:MPL) share price today?

The private health insurer has made an announcement about its premiums

| More on:
A doctor in a white coat with a stethoscope around her neck holds her hands upwards as if to ask 'why' as she sits at her desk and looks at her computer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is seesawing today after the company said it would be deferring its premium increase.

At the time of writing, the private health insurance giant's shares are exchanging hands for $3.38, the same as yesterday's closing price. However, they have spent time in the red and the green today.

Medibank pushes back date on premium increase

According to the update, Medibank has returned roughly $135 million in COVID-19 savings to customers. This comes after it decided to defer next year's premium increase for 5 months.

Originally, Medibank and Ahm health insurance premiums were set to lift by an average of 3.1% from April 2022. The adjustment will be the lowest average premium increase in the last 21 years. However, this now won't happen until 1 September 2022.

The latest financial support package boosts the company's reputation in becoming socially responsible. So far, Medibank has returned about $435 million of relief to policyholders. However, the news hasn't done much for the Medibank share price.

Medibank CEO David Koczkar commented:

We have worked hard to deliver our lowest average premium increase in 21 years, recognising the importance of keeping private health insurance affordable.

While we know no one likes their premium to go up, healthcare costs are continuing to increase at a rate much higher than general inflation.

We support the Government's commitment to reform the prostheses list, which could save the industry up to $500 million, with savings expected to be realised over the next 4 years. We remain committed to passing on any related savings to our customers through lower premium increases and we will continue to advocate for changes that support the long-term sustainability and affordability of private health insurance.

Medibank share price snapshot

Over the last 12 months, the Medibank share price has been on par with the market, up 12%. In comparison, the S&P/ASX 200 Index (ASX: XJO) has also risen by 12% over the same time frame.

It's worth noting that Medibank shares reached a 52-week high of $3.62 in September, before moving in a sideways channel.

Medibank has a market capitalisation of roughly $9.3 billion, with approximately 2.75 billion shares on issue.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »